| 摘要 |
FIELD: medicine. ^ SUBSTANCE: group of inventions relates to medicine and is intended for treatment of malignant tumor in patient. At least one fixed dose of pertuzumab is introduced. Fixed dose is selected from group of approximately 420 mg, 525 mg, 840 m, 1050 mg. ^ EFFECT: group of inventions makes it possible to simplify dose selection for patient, reduce costs for individual selection of pertuzumab dose. ^ 9 cl, 4 tbl, 14 dwg |
